The serum level of ApoJ level was found to be significantly increased in type II diabetes patients and in patients with either a developing coronary heart disease or myocardial infarction as compared to healthy individuals, but its level showed no correlation with the number of vessels with documented atherosclerotic damage [18, 19]. This evidence concerns the gene CLU and coronary artery disorder.